{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T06:14:08Z","timestamp":1759385648444,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Shanghai  Key Clinical  Specialty Construction program","award":["ZK2019B24"],"award-info":[{"award-number":["ZK2019B24"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81101241","81672009","81871640"],"award-info":[{"award-number":["81101241","81672009","81871640"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Pujiang Talent Plan","award":["12PJ1401600"],"award-info":[{"award-number":["12PJ1401600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11262-020-01787-9","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T15:04:23Z","timestamp":1598367863000},"page":"677-686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An antiviral drug-resistant mutant of hepatitis B virus with high replication capacity in association with a large in-frame deletion in the preS1 region of viral surface gene"],"prefix":"10.1007","volume":"56","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7003-0430","authenticated-orcid":false,"given":"Yanli","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuping","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"issue":"9401","key":"1787_CR1","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/S0140-6736(03)15108-2","volume":"362","author":"CL Lai","year":"2003","unstructured":"Lai CL, Ratziu V, Yuen MF, Poynard T (2003) Viral hepatitis B. Lancet 362(9401):2089\u20132094. https:\/\/doi.org\/10.1016\/S0140-6736(03)15108-2","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1787_CR2","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1016\/S1386-6532(05)80024-1","volume":"34","author":"JP Villeneuve","year":"2005","unstructured":"Villeneuve JP (2005) The natural history of chronic hepatitis B virus infection. J Clin Virol 34(Suppl 1):S139\u2013142","journal-title":"J Clin Virol"},{"issue":"10","key":"1787_CR3","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J","volume":"61","author":"RP Beasley","year":"1988","unstructured":"Beasley RP (1988) Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61(10):1942\u20131956","journal-title":"Cancer"},{"issue":"Suppl 1","key":"1787_CR4","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/S1386-6532(05)80015-0","volume":"34","author":"M Buti","year":"2005","unstructured":"Buti M, Rodriguez-Frias F, Jardi R, Esteban R (2005) Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes. J Clin Virol 34(Suppl 1):S79\u201382","journal-title":"J Clin Virol"},{"issue":"Suppl 1","key":"1787_CR5","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1016\/S1386-6532(05)80025-3","volume":"34","author":"YF Liaw","year":"2005","unstructured":"Liaw YF (2005) The current management of HBV drug resistance. J Clin Virol 34(Suppl 1):S143\u2013146","journal-title":"J Clin Virol"},{"issue":"Suppl 1","key":"1787_CR6","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1016\/S1386-6532(05)80023-X","volume":"34","author":"S Tong","year":"2005","unstructured":"Tong S (2005) Mechanism of HBV genome variability and replication of HBV mutants. J Clin Virol 34(Suppl 1):S134\u2013138","journal-title":"J Clin Virol"},{"issue":"5","key":"1787_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2893.2004.00564.x","volume":"11","author":"P Andreone","year":"2004","unstructured":"Andreone P, Gramenzi A, Cursaro C, Biselli M, Camma C, Trevisani F, Bernardi M (2004) High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance. J Viral Hepat 11(5):439\u2013442. https:\/\/doi.org\/10.1111\/j.1365-2893.2004.00564.x","journal-title":"J Viral Hepat"},{"issue":"1","key":"1787_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/jhep.2001.21163","volume":"33","author":"YF Fan","year":"2001","unstructured":"Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, Chang TT, Lei HY, Shiau AL, Su IJ (2001) Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33(1):277\u2013286. https:\/\/doi.org\/10.1053\/jhep.2001.21163","journal-title":"Hepatology"},{"issue":"2","key":"1787_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","volume":"61","author":"T Pollicino","year":"2014","unstructured":"Pollicino T, Cacciola I, Saffioti F, Raimondo G (2014) Hepatitis B virus PreS\/S gene variants: pathobiology and clinical implications. J Hepatol 61(2):408\u2013417. https:\/\/doi.org\/10.1016\/j.jhep.2014.04.041","journal-title":"J Hepatol"},{"issue":"23","key":"1787_CR10","doi-asserted-by":"publisher","first-page":"11827","DOI":"10.1128\/JVI.75.23.11827-11833.2001","volume":"75","author":"X Lin","year":"2001","unstructured":"Lin X, Yuan ZH, Wu L, Ding JP, Wen YM (2001) A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol 75(23):11827\u201311833. https:\/\/doi.org\/10.1128\/JVI.75.23.11827-11833.2001","journal-title":"J Virol"},{"issue":"1","key":"1787_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2003.07.003","volume":"61","author":"H Yang","year":"2004","unstructured":"Yang H, Westland C, Xiong S, Delaney WE (2004) In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vector. Antiviral Res 61(1):27\u201336","journal-title":"Antiviral Res"},{"issue":"2","key":"1787_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jmv.21393","volume":"81","author":"ZM Ma","year":"2009","unstructured":"Ma ZM, Lin X, Wang YX, Tian XC, Xie YH, Wen YM (2009) A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus. J Med Virol 81(2):230\u2013237. https:\/\/doi.org\/10.1002\/jmv.21393","journal-title":"J Med Virol"},{"issue":"2","key":"1787_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/jmv.20453","volume":"77","author":"JM Zhang","year":"2005","unstructured":"Zhang JM, Yao X, Wang YX, Liu F, Ma ZM, Weng XH, Wen YM (2005) High replicative full-length lamivudine-resistant hepatitis B virus isolated during acute exacerbations. J Med Virol 77(2):203\u2013208. https:\/\/doi.org\/10.1002\/jmv.20453","journal-title":"J Med Virol"},{"issue":"19","key":"1787_CR14","doi-asserted-by":"publisher","first-page":"10167","DOI":"10.1128\/JVI.00819-11","volume":"85","author":"Y Qin","year":"2011","unstructured":"Qin Y, Tang X, Garcia T, Hussain M, Zhang J, Lok A, Wands J, Li J, Tong S (2011) Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity. J Virol 85(19):10167\u201310177. https:\/\/doi.org\/10.1128\/JVI.00819-11","journal-title":"J Virol"},{"key":"1787_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/v9040062","author":"H Jia","year":"2017","unstructured":"Jia H, Qin Y, Chen C, Zhang F, Li C, Zong L, Wang Y, Zhang J, Li J, Wen Y, Tong S (2017) The envelope gene of hepatitis B virus is implicated in both differential virion secretion and genome replication capacities between genotype B and genotype C isolates. Viruses. https:\/\/doi.org\/10.3390\/v9040062","journal-title":"Viruses"},{"issue":"2","key":"1787_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/JVI.80.2.587-595.2006","volume":"80","author":"M Guarnieri","year":"2006","unstructured":"Guarnieri M, Kim KH, Bang G, Li J, Zhou Y, Tang X, Wands J, Tong S (2006) Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression. J Virol 80(2):587\u2013595","journal-title":"J Virol"},{"issue":"6","key":"1787_CR17","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1128\/JCM.02477-05","volume":"44","author":"C Osiowy","year":"2006","unstructured":"Osiowy C, Villeneuve JP, Heathcote EJ, Giles E, Borlang J (2006) Detection of rtN236T and rtA181V\/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J Clin Microbiol 44(6):1994\u20131997. https:\/\/doi.org\/10.1128\/JCM.02477-05","journal-title":"J Clin Microbiol"},{"key":"1787_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.virusres.2017.03.021","volume":"235","author":"H Zhou","year":"2017","unstructured":"Zhou H, Gewaily D, Ahn SH, Preskill C, Wang Y, Zong L, Zhang J, Han KH, Wands J, Li J, Tong S (2017) Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer. Virus Res 235:86\u201395. https:\/\/doi.org\/10.1016\/j.virusres.2017.03.021","journal-title":"Virus Res"},{"issue":"5","key":"1787_CR19","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1053\/j.gastro.2007.09.002","volume":"133","author":"CH Chen","year":"2007","unstructured":"Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS (2007) Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 133(5):1466\u20131474. https:\/\/doi.org\/10.1053\/j.gastro.2007.09.002","journal-title":"Gastroenterology"},{"issue":"9","key":"1787_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00535-007-2085-1","volume":"42","author":"ZY Gao","year":"2007","unstructured":"Gao ZY, Li T, Wang J, Du JM, Li YJ, Li J, Lu FM, Zhuang H (2007) Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol 42(9):761\u2013768. https:\/\/doi.org\/10.1007\/s00535-007-2085-1","journal-title":"J Gastroenterol"},{"issue":"7","key":"1787_CR21","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/j.1440-1746.2006.04515.x","volume":"22","author":"CL Lin","year":"2007","unstructured":"Lin CL, Liu CH, Chen W, Huang WL, Chen PJ, Lai MY, Chen DS, Kao JH (2007) Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 22(7):1098\u20131103. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04515.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"1787_CR22","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/jmv.21208","volume":"80","author":"HS Mun","year":"2008","unstructured":"Mun HS, Lee SA, Jee Y, Kim H, Park JH, Song BC, Yoon JH, Kim YJ, Lee HS, Hyun JW, Hwang ES, Kook YH, Kim BJ (2008) The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J Med Virol 80(7):1189\u20131194. https:\/\/doi.org\/10.1002\/jmv.21208","journal-title":"J Med Virol"},{"issue":"2","key":"1787_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1006\/viro.2000.0432","volume":"273","author":"S Gunther","year":"2000","unstructured":"Gunther S, Piwon N, Jung A, Iwanska A, Schmitz H, Will H (2000) Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. Virology 273(2):286\u2013299. https:\/\/doi.org\/10.1006\/viro.2000.0432","journal-title":"Virology"},{"issue":"7","key":"1787_CR24","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1128\/JVI.71.7.5449-5454.1997","volume":"71","author":"M Melegari","year":"1997","unstructured":"Melegari M, Scaglioni PP, Wands JR (1997) The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted. J Virol 71(7):5449\u20135454","journal-title":"J Virol"},{"issue":"6","key":"1787_CR25","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/0016-5085(95)90760-2","volume":"109","author":"CM Chu","year":"1995","unstructured":"Chu CM, Yeh CT, Sheen IS, Liaw YF (1995) Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B. Gastroenterology 109(6):1926\u20131932. https:\/\/doi.org\/10.1016\/0016-5085(95)90760-2","journal-title":"Gastroenterology"},{"issue":"3","key":"1787_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5009\/gnl.2008.2.3.166","volume":"2","author":"MS Son","year":"2008","unstructured":"Son MS, Yoo JH, Kwon CI, Ko KH, Hong SP, Hwang SG, Park PW, Park CK, Rim KS (2008) Associations of expressions of HBcAg and HBsAg with the histologic activity of liver disease and viral replication. Gut Liver 2(3):166\u2013173. https:\/\/doi.org\/10.5009\/gnl.2008.2.3.166","journal-title":"Gut Liver"},{"issue":"16","key":"1787_CR27","doi-asserted-by":"publisher","first-page":"8308","DOI":"10.1128\/JVI.00833-10","volume":"84","author":"WS Mason","year":"2010","unstructured":"Mason WS, Liu C, Aldrich CE, Litwin S, Yeh MM (2010) Clonal expansion of normal-appearing human hepatocytes during chronic hepatitis B virus infection. J Virol 84(16):8308\u20138315. https:\/\/doi.org\/10.1128\/JVI.00833-10","journal-title":"J Virol"},{"key":"1787_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/v9040075","author":"T Tu","year":"2017","unstructured":"Tu T, Budzinska MA, Shackel NA, Urban S (2017) HBV DNA integration: molecular mechanisms and clinical implications. Viruses. https:\/\/doi.org\/10.3390\/v9040075","journal-title":"Viruses"},{"issue":"9","key":"1787_CR29","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1128\/JVI.70.9.5845-5851.1996","volume":"70","author":"VE Buckwold","year":"1996","unstructured":"Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH (1996) Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 70(9):5845\u20135851","journal-title":"J Virol"},{"issue":"2","key":"1787_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1006\/viro.1996.0655","volume":"226","author":"K Moriyama","year":"1996","unstructured":"Moriyama K, Okamoto H, Tsuda F, Mayumi M (1996) Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 226(2):269\u2013280. https:\/\/doi.org\/10.1006\/viro.1996.0655","journal-title":"Virology"},{"issue":"12","key":"1787_CR31","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1128\/jvi.77.12.6601-6612.2003","volume":"77","author":"S Parekh","year":"2003","unstructured":"Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, Khan N, Tr\u00e9po C, Wands J, Tong S (2003) Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77(12):6601\u20136612. https:\/\/doi.org\/10.1128\/jvi.77.12.6601-6612.2003","journal-title":"J Virol"},{"issue":"4","key":"1787_CR32","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jhep.2010.01.006","volume":"52","author":"CH Chen","year":"2010","unstructured":"Chen CH, Lee CM, Tung WC, Wang JH, Hung CH, Hu TH, Wang JC, Lu SN, Changchien CS (2010) Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance. J Hepatol 52(4):478\u2013485. https:\/\/doi.org\/10.1016\/j.jhep.2010.01.006","journal-title":"J Hepatol"},{"issue":"1\u20132","key":"1787_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cca.2009.07.016","volume":"408","author":"YZ Wang","year":"2009","unstructured":"Wang YZ, Xiao JH, Ruan LH, Zhang HY, Chen M, Pu XK, Shen HY, Wu GX (2009) Detection of the rtA181V\/T and rtN236T mutations associated with resistance to adefovir dipivoxil using a ligase detection reaction assay. Clin Chim Acta 408(1\u20132):70\u201374. https:\/\/doi.org\/10.1016\/j.cca.2009.07.016","journal-title":"Clin Chim Acta"},{"issue":"2","key":"1787_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.21534","volume":"45","author":"I Rapti","year":"2007","unstructured":"Rapti I, Dimou E, Mitsoula P, Hadziyannis SJ (2007) Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B. Hepatology 45(2):307\u2013313. https:\/\/doi.org\/10.1002\/hep.21534","journal-title":"Hepatology"},{"issue":"2","key":"1787_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jhep.2005.10.018","volume":"44","author":"SK Fung","year":"2006","unstructured":"Fung SK, Chae HB, Fontana RJ, Conjeevaram H, Marrero J, Oberhelman K, Hussain M, Lok AS (2006) Virologic response and resistance to adefovir in patients with chronic hepatitis B. J Hepatol 44(2):283\u2013290. https:\/\/doi.org\/10.1016\/j.jhep.2005.10.018","journal-title":"J Hepatol"},{"issue":"10","key":"1787_CR36","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1136\/gut.2005.077099","volume":"55","author":"JE Yeon","year":"2006","unstructured":"Yeon JE, Yoo W, Hong SP, Chang YJ, Yu SK, Kim JH, Seo YS, Chung HJ, Moon MS, Kim SO, Byun KS, Lee CH (2006) Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil. Gut 55(10):1488\u20131495. https:\/\/doi.org\/10.1136\/gut.2005.077099","journal-title":"Gut"},{"issue":"7","key":"1787_CR37","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/liv.12343","volume":"34","author":"Y Liu","year":"2014","unstructured":"Liu Y, Miller MD, Kitrinos KM (2014) HBV clinical isolates expressing adefovir resistance mutations show similar tenofovir susceptibilities across genotypes B, C and D. Liver Int 34(7):1025\u20131032. https:\/\/doi.org\/10.1111\/liv.12343","journal-title":"Liver Int"},{"issue":"12","key":"1787_CR38","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1128\/JVI.03328-12","volume":"87","author":"R Hong","year":"2013","unstructured":"Hong R, Bai W, Zhai J, Liu W, Li X, Zhang J, Cui X, Zhao X, Ye X, Deng Q, Tiollais P, Wen Y, Liu J, Xie Y (2013) Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes. J Virol 87(12):6615\u20136624. https:\/\/doi.org\/10.1128\/JVI.03328-12","journal-title":"J Virol"},{"issue":"12","key":"1787_CR39","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.7150\/thno.44715","volume":"10","author":"Z Shen","year":"2020","unstructured":"Shen Z, Wu J, Gao Z, Wang J, Zhu H, Mao R, Wang X, Zhang J, Xie Y, Liu J (2020) Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection. Theranostics 10(12):5600\u20135612. https:\/\/doi.org\/10.7150\/thno.44715","journal-title":"Theranostics"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-020-01787-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-020-01787-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-020-01787-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:04:17Z","timestamp":1629849857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-020-01787-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1787"],"URL":"https:\/\/doi.org\/10.1007\/s11262-020-01787-9","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"type":"print","value":"0920-8569"},{"type":"electronic","value":"1572-994X"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"assertion":[{"value":"24 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study reporting research involving Human Participants was conducted in accordance with the ethics principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study was approved by our institutional review board and written informed consent was obtained from all subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}